Pharmacological inhibition of MET in Tpl2-/- mice is somewhat effective, decreasing overall tumor burden and conversion to cSCC, but doesn’t completely eliminate tumor growth or restore numbers to the level of wild type controls [25]. This evidence concerns the gene MET and neoplasm.